News
For the abstract submission details, please visit the InfoReady Portal. The Drexel University/Spark Therapeutics Gene Therapy Symposium, a co-sponsored event, is Thursday, December 7, 2023, from ...
Background: KRAS mutations account for a significant proportion of oncogenic mutations in cancers of the lung, colon, pancreas, and other organs. Cancers with KRAS G12C mutations are now targetable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results